How The Experts Treat Hematologic Malignancies: A Roadmap to Treatment
By the end of 2009, it was estimated that 65,000 people were living with multiple myeloma, 675,670 with lymphoma, and 290,015 with or in remission from some form of leukemia. Given the frequency of the occurrence of these diseases and the complexities of their individual clinical presentations and courses, there is a need for primary care and specialty physicians to engage in an in-depth examination and discussion of the emerging data that underlie optimal management of these patient populations. Comprehensive Cancer Centers remain at the forefront in their generation and application of these emerging data to improve patient outcomes.
Download a PDF version of the full issue.